Pharmafile Logo
Pharmafocus logo
Advanced Search

Affectis Pharmaceuticals

Showing 1 posts of 1 posts found.

Merck Serono headquarters

Merck Serono signs neurodegenerative collaboration

June 9, 2011
Research and Development Affectis Pharmaceuticals, Merck Serono

Merck Serono has struck a deal with biotech firm Affectis Pharmaceuticals to develop oral neurodegeneration compounds. The companies will commercialise …

News
The Gateway to Local Adoption Series

Latest content

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026

Mavatar announces research collaboration with Sobi

January 6, 2026

DemeRx announces completion of alcohol use disorder treatment trial

January 5, 2026

Andera Partners leads financing for asthma treatment company Spiro Medical

January 5, 2026